Register entry
EyePoint US, Inc.
- Registered sites
- 2
- Drug products
- 0
- Live patents
- 5
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| EyePoint US, Inc. | Northbridge, MAUnited States | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3036800967 |
| EyePoint US, Inc. | Watertown, MAUnited States | Labelling, Finished drug manufacture | 3005508657 |
Exclusivity
Patents
5Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| DEXYCU KIT | DEXAMETHASONE | May 2032 |
| DEXYCU KIT | DEXAMETHASONE | May 2034 |
| DEXYCU KIT | DEXAMETHASONE | Jun 2034 |
| DEXYCU KIT | DEXAMETHASONE | Jun 2039 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.